会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Scaffold polypeptides for heterologous peptide display
    • 用于异源肽显示的支架多肽
    • US08063019B2
    • 2011-11-22
    • US11917057
    • 2006-06-08
    • Robbie WoodmanJohannes Tsung-Han YehSophie LaurensonPaul Ko Ferrigno
    • Robbie WoodmanJohannes Tsung-Han YehSophie LaurensonPaul Ko Ferrigno
    • A61K38/16C07K14/00
    • C07K14/8139C07K7/06C12N15/1044
    • The present invention relates to the use of Stefin A as a scaffold protein for the display of inserted peptides, particularly wherein the Stefin A is a human Stefin A. Several mutations are advantageously made in the wild type stefin A sequence to improve it as a scaffold; preferably the Stefin A comprises a heterologous peptide insertion at the Leu 73 site. Furthermore, preferably the scaffold protein comprises a V48D mutation; preferably the scaffold protein comprises a G4W mutation. Preferably the scaffold comprises Leu73, V48D and G4W mutations. The invention also relates to the scaffold proteins themselves, in particular a stefin A polypeptide having the Leu73, V48D and G4W mutations, such as shown as SEQ ID NO: 1. The invention also relates to a method for identifying binding proteins and to peptide A (RLNKPLPSLPV) and its use in treating yeast infections.
    • 本发明涉及使用Stefin A作为展示插入肽的支架蛋白,特别是其中Stefin A是人SteFen A.几种突变有利地在野生型stefin A序列中制成,以改善其作为支架 ; 优选地,Stefin A包含在Leu 73位点处的异源肽插入。 此外,优选地,支架蛋白包含V48D突变; 优选地,支架蛋白包含G4W突变。 优选地,所述支架包含Leu73,V48D和G4W突变。 本发明还涉及支架蛋白本身,特别是具有Leu73,V48D和G4W突变的stefin A多肽,如SEQ ID NO:1所示。本发明还涉及鉴定结合蛋白和肽A的方法 (RLNKPLPSLPV)及其在治疗酵母菌感染中的应用。
    • 5. 发明授权
    • Scaffold polypeptides for heterologous peptide display
    • 用于异源肽显示的支架多肽
    • US08481491B2
    • 2013-07-09
    • US13243318
    • 2011-09-23
    • Robbie WoodmanJohannes Tsung-Han YehSophie LaurensonPaul Ko Ferrigno
    • Robbie WoodmanJohannes Tsung-Han YehSophie LaurensonPaul Ko Ferrigno
    • A61K38/16C07K14/00
    • C07K14/8139C07K7/06C12N15/1044
    • The present invention relates to the use of Stefin A as a scaffold protein for the display of inserted peptides, particularly wherein the Stefin A is a human Stefin A. Several mutations are advantageously made in the wild type stefin A sequence to improve it as a scaffold; preferably the Stefin A comprises a heterologous peptide insertion at the Leu 73 site. Furthermore, preferably the scaffold protein comprises a V48D mutation; preferably the scaffold protein comprises a G4W mutation. Preferably the scaffold comprises Leu73, V48D and G4W mutations. The invention also relates to the scaffold proteins themselves, in particular a stefin A polypeptide having the Leu73, V48D and G4W mutations, such as shown as SEQ ID NO: 1. The invention also relates to a method for identifying binding proteins and to peptide A (RLNKPLPSLPV, SEQ ID NO: 30) and its use in treating yeast infections.
    • 本发明涉及使用Stefin A作为展示插入肽的支架蛋白,特别是其中Stefin A是人SteFen A.几种突变有利地在野生型stefin A序列中制成,以改善其作为支架 ; 优选地,Stefin A包含在Leu 73位点处的异源肽插入。 此外,优选地,支架蛋白包含V48D突变; 优选地,支架蛋白包含G4W突变。 优选地,所述支架包含Leu73,V48D和G4W突变。 本发明还涉及支架蛋白本身,特别是具有Leu73,V48D和G4W突变的stefin A多肽,如SEQ ID NO:1所示。本发明还涉及鉴定结合蛋白和肽A的方法 (RLNKPLPSLPV,SEQ ID NO:30)及其在治疗酵母菌感染中的应用。
    • 6. 发明申请
    • Scaffold
    • 脚手架
    • US20080207509A1
    • 2008-08-28
    • US11917057
    • 2006-06-08
    • Robbie WoodmanJohannes Tsung-Hau YehSophie LaurensonPaul Ko Ferrigno
    • Robbie WoodmanJohannes Tsung-Hau YehSophie LaurensonPaul Ko Ferrigno
    • A61K38/00C07K16/00C07H21/04G01N33/53
    • C07K14/8139C07K7/06C12N15/1044
    • The present invention relates to the use of Stefin A as a scaffold protein for the display of inserted peptides, particularly wherein the Stefin A is a human Stefin A. Several mutations are advantageously made in the wild type stefin A sequence to improve it as a scaffold; preferably the Stefin A comprises a heterologous peptide insertion at the Leu 73 site. Furthermore, preferably the scaffold protein comprises a V48D mutation; preferably the scaffold protein comprises a G4W mutation. Preferably the scaffold comprises Leu73, V48D and G4W mutations. The invention also relates to the scaffold proteins themselves, in particular a stefin A polypeptide having the Leu73, V48D and G4W mutations, such as shown as SEQ ID NO: 1. The invention also relates to a method for identifying binding proteins and to peptide A (RLNKPLPSLPV) and its use in treating yeast infections.
    • 本发明涉及使用Stefin A作为展示插入肽的支架蛋白,特别是其中Stefin A是人SteFen A.几种突变有利地在野生型stefin A序列中制成,以改善其作为支架 ; 优选地,Stefin A包含在Leu 73位点处的异源肽插入。 此外,优选地,支架蛋白包含V48D突变; 优选地,支架蛋白包含G4W突变。 优选地,所述支架包含Leu73,V48D和G4W突变。 本发明还涉及支架蛋白本身,特别是具有Leu73,V48D和G4W突变的stefin A多肽,如SEQ ID NO:1所示。本发明还涉及鉴定结合蛋白和肽A的方法 (RLNKPLPSLPV)及其在治疗酵母菌感染中的应用。
    • 7. 发明申请
    • SCAFFOLD POLYPEPTIDES FOR HETEROLOGOUS PEPTIDE DISPLAY
    • 用于异位肽显示的SCAFFOLD POLYPEPTIDES
    • US20120190819A1
    • 2012-07-26
    • US13243318
    • 2011-09-23
    • Robbie WoodmanJohannes Tsung-Han YehSophie LaurensonPaul Ko Ferrigno
    • Robbie WoodmanJohannes Tsung-Han YehSophie LaurensonPaul Ko Ferrigno
    • C07K19/00C07K14/47
    • C07K14/8139C07K7/06C12N15/1044
    • The present invention relates to the use of Stefin A as a scaffold protein for the display of inserted peptides, particularly wherein the Stefin A is a human Stefin A. Several mutations are advantageously made in the wild type stefin A sequence to improve it as a scaffold; preferably the Stefin A comprises a heterologous peptide insertion at the Leu 73 site. Furthermore, preferably the scaffold protein comprises a V48D mutation; preferably the scaffold protein comprises a G4W mutation. Preferably the scaffold comprises Leu73, V48D and G4W mutations. The invention also relates to the scaffold proteins themselves, in particular a stefin A polypeptide having the Leu73, V48D and G4W mutations, such as shown as SEQ ID NO: 1. The invention also relates to a method for identifying binding proteins and to peptide A (RLNKPLPSLPV) and its use in treating yeast infections.
    • 本发明涉及使用Stefin A作为展示插入肽的支架蛋白,特别是其中Stefin A是人SteFen A.几种突变有利地在野生型stefin A序列中制成,以改善其作为支架 ; 优选地,Stefin A包含在Leu 73位点处的异源肽插入。 此外,优选地,支架蛋白包含V48D突变; 优选地,支架蛋白包含G4W突变。 优选地,所述支架包含Leu73,V48D和G4W突变。 本发明还涉及支架蛋白本身,特别是具有Leu73,V48D和G4W突变的stefin A多肽,如SEQ ID NO:1所示。本发明还涉及鉴定结合蛋白和肽A的方法 (RLNKPLPSLPV)及其在治疗酵母菌感染中的应用。